Olaparib in German routine clinical practice: Updated interim results of the non-interventional study C-PATROL.

被引：4
作者：
Marme, Frederik
Hilpert, Felix
Welslau, Manfred
El-Balat, Ahmed
Grischke, Eva-Maria
Schinkothe, Timo
Glowik, Regina
Sehouli, Jalid
机构：
[1] Heidelberg Univ, Natl Ctr Tumor Dis, Dept Gynecol, Heidelberg, Germany
[2] Onkolog Therapiezent Krankenhaus Jerusalem, Hamburg, Germany
[3] Hematol Oncol Practice, Aschaffenburg, Germany
[4] Univ Hosp Frankfurt, Frankfurt, Germany
[5] Univ Frauenklin Tubingen, Eberhard Karls Univ, Tubingen, Germany
[6] Inst Innovat & Med, Munich, Germany
[7] AstraZeneca GmbH, Wedel, DE USA
[8] Charite Med Univ, Dept Gynecol, Campus Virchow Clin, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e17549
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17549
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PEARL, a non-interventional study on real-world use of alirocumab in German clinical practice: results in patients with and without diabetes
    Parhofer, K. G.
    von Stritzky, B.
    Pietschmann, N.
    Paar, W.
    DIABETOLOGIA, 2018, 61 : S559 - S560
  • [32] PROMiS (a prospective, non-interventional study in US patients with relapsing-remitting multiple sclerosis treated with alemtuzumab in routine clinical practice): interim results on treatment history and satisfaction with alemtuzumab
    Khatri, B. O.
    Morawski, J.
    Chung, L.
    Poole, E.
    Bury, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 948 - 949
  • [33] Efficacy and tolerability of alirocumab in Austrian clinical practice - results of the non-interventional PEARL-AT study
    Leitner, Deborah R.
    Toplak, Hermann
    Kedenko, Ludmilla
    Steinmaurer, Thomas
    Graeff, Verena
    Metzner, Thomas
    Schwaiger, Elisabeth M.
    Prager, Rudolf
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (09) : 1419 - 1425
  • [34] The Antidepressant Agomelatine in Daily Practice: Results of the Non-Interventional Study VIVALDI
    Laux, G.
    PHARMACOPSYCHIATRY, 2012, 45 (07) : 284 - 291
  • [35] Efficacy and safety of tirbanibulin in actinic keratoses. Interim results of a non-interventional study
    Heppt, M.
    Hadshiew, I.
    Kempf, A.
    Melzer, A.
    Berking, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 69 - 70
  • [36] 2016 Interim analysis of the prospective, non-interventional study JAKoMo: new insights into ruxolitinib treatment of myelofibrosis in daily clinical routine
    Geer, T.
    Heinrich, B.
    Jacobasch, L.
    Tesch, H.
    Wehmeyer, J.
    Schlag, R.
    Groeschl, B.
    Markhauser, M.
    Bachhuber, P.
    Koschmieder, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 149 - 149
  • [37] Sequential treatment with pazopanib followed by nivolumab in patients with renal cell carcinoma: Updated interim results of the non-interventional study PAZOREAL.
    Bedke, Jens
    Boegemann, Martin
    Schostak, Martin
    Hering-Schubert, Christiane
    Welslau, Manfred
    Schleicher, Jan
    Petzoldt, Alexander
    Doehn, Christian
    Gruellich, Carsten
    Goebell, Peter-Juergen
    Steiner, Thomas
    Degenkolbe, Elisa
    Hanson, Sven
    Gruenwald, Viktor
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Nintedanib plus docetaxel in routine clinical practice: VARGADO, a German prospective non-interventional study (NIS) reflecting routine treatment conditions in an evolving NSCLC treatment landscape
    Grohe, C.
    Zander, I.
    Luedtke-Heckenkamp, K.
    Blau, W.
    Krueger, S.
    Franke, C.
    Mueller-Huesmann, H.
    Brueckl, W. M.
    Basara, N.
    Ukena, D.
    Lang, S.
    Atz, J.
    Kaiser, R.
    ANNALS OF ONCOLOGY, 2018, 29 : 545 - 545
  • [39] TOCILIZUMAB, DMARDS AND GLUCOCORTICOIDS IN RHEUMATOID ARTHRITIS - INTERIM ANALYSIS OF THE GERMAN NON-INTERVENTIONAL STUDY ICHIBAN
    Specker, C.
    Kaufmann, J.
    Vollmer, M. A.
    Kellner, H.
    Hoehle, M.
    Kuehne, C.
    Volberg, C.
    Henes, J. C.
    Zinke, S.
    Moosig, F.
    Bohl-Buehler, M.
    Sieburg, M.
    Aringer, M.
    Hofmann, M. W.
    Hellmann, P.
    Fliedner, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 494 - 495
  • [40] ASSESSING QUALITY OF LIFE AND PERSISTENCE IN PATIENTS PRESCRIBED MIRABEGRON IN ROUTINE CLINICAL PRACTICE; RESULTS FROM A PAN-EUROPEAN NON-INTERVENTIONAL STUDY
    Freeman, R. M.
    Grill, R.
    Kachlirova, Z.
    Choudhury, N.
    Stari, A.
    Huang, M.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2017, 28 : S120 - S121
12345